IBDEI35Z ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,50525,0)
 ;;=N52.33^^193^2494^42
 ;;^UTILITY(U,$J,358.3,50525,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50525,1,3,0)
 ;;=3^Erectile Dysfunction Following Urethral Surgery
 ;;^UTILITY(U,$J,358.3,50525,1,4,0)
 ;;=4^N52.33
 ;;^UTILITY(U,$J,358.3,50525,2)
 ;;=^5015759
 ;;^UTILITY(U,$J,358.3,50526,0)
 ;;=N52.32^^193^2494^39
 ;;^UTILITY(U,$J,358.3,50526,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50526,1,3,0)
 ;;=3^Erectile Dysfunction Following Radical Cystectomy
 ;;^UTILITY(U,$J,358.3,50526,1,4,0)
 ;;=4^N52.32
 ;;^UTILITY(U,$J,358.3,50526,2)
 ;;=^5015758
 ;;^UTILITY(U,$J,358.3,50527,0)
 ;;=N52.31^^193^2494^40
 ;;^UTILITY(U,$J,358.3,50527,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50527,1,3,0)
 ;;=3^Erectile Dysfunction Following Radical Prostatectomy
 ;;^UTILITY(U,$J,358.3,50527,1,4,0)
 ;;=4^N52.31
 ;;^UTILITY(U,$J,358.3,50527,2)
 ;;=^5015757
 ;;^UTILITY(U,$J,358.3,50528,0)
 ;;=N52.2^^193^2494^46
 ;;^UTILITY(U,$J,358.3,50528,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50528,1,3,0)
 ;;=3^Erectile Dysfunction,Drug-Induced
 ;;^UTILITY(U,$J,358.3,50528,1,4,0)
 ;;=4^N52.2
 ;;^UTILITY(U,$J,358.3,50528,2)
 ;;=^5015756
 ;;^UTILITY(U,$J,358.3,50529,0)
 ;;=N52.03^^193^2494^37
 ;;^UTILITY(U,$J,358.3,50529,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50529,1,3,0)
 ;;=3^Erectile Dysfunction Comb Artrl Insuff & Corporo-Venous Occlusv
 ;;^UTILITY(U,$J,358.3,50529,1,4,0)
 ;;=4^N52.03
 ;;^UTILITY(U,$J,358.3,50529,2)
 ;;=^5015754
 ;;^UTILITY(U,$J,358.3,50530,0)
 ;;=N52.02^^193^2494^38
 ;;^UTILITY(U,$J,358.3,50530,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50530,1,3,0)
 ;;=3^Erectile Dysfunction Corporo-Venous Occlusive
 ;;^UTILITY(U,$J,358.3,50530,1,4,0)
 ;;=4^N52.02
 ;;^UTILITY(U,$J,358.3,50530,2)
 ;;=^5015753
 ;;^UTILITY(U,$J,358.3,50531,0)
 ;;=N52.1^^193^2494^45
 ;;^UTILITY(U,$J,358.3,50531,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50531,1,3,0)
 ;;=3^Erectile Dysfunction d/t Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,50531,1,4,0)
 ;;=4^N52.1
 ;;^UTILITY(U,$J,358.3,50531,2)
 ;;=^5015755
 ;;^UTILITY(U,$J,358.3,50532,0)
 ;;=N52.01^^193^2494^44
 ;;^UTILITY(U,$J,358.3,50532,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50532,1,3,0)
 ;;=3^Erectile Dysfunction d/t Arterial Insufficiency
 ;;^UTILITY(U,$J,358.3,50532,1,4,0)
 ;;=4^N52.01
 ;;^UTILITY(U,$J,358.3,50532,2)
 ;;=^5015752
 ;;^UTILITY(U,$J,358.3,50533,0)
 ;;=N95.2^^193^2494^88
 ;;^UTILITY(U,$J,358.3,50533,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50533,1,3,0)
 ;;=3^Postmenopausal Atrophic Vaginitis
 ;;^UTILITY(U,$J,358.3,50533,1,4,0)
 ;;=4^N95.2
 ;;^UTILITY(U,$J,358.3,50533,2)
 ;;=^270577
 ;;^UTILITY(U,$J,358.3,50534,0)
 ;;=R30.9^^193^2494^69
 ;;^UTILITY(U,$J,358.3,50534,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50534,1,3,0)
 ;;=3^Micturition Painful,Unspec
 ;;^UTILITY(U,$J,358.3,50534,1,4,0)
 ;;=4^R30.9
 ;;^UTILITY(U,$J,358.3,50534,2)
 ;;=^5019324
 ;;^UTILITY(U,$J,358.3,50535,0)
 ;;=R30.0^^193^2494^28
 ;;^UTILITY(U,$J,358.3,50535,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50535,1,3,0)
 ;;=3^Dysuria
 ;;^UTILITY(U,$J,358.3,50535,1,4,0)
 ;;=4^R30.0
 ;;^UTILITY(U,$J,358.3,50535,2)
 ;;=^5019322
 ;;^UTILITY(U,$J,358.3,50536,0)
 ;;=R33.9^^193^2494^119
 ;;^UTILITY(U,$J,358.3,50536,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50536,1,3,0)
 ;;=3^Urine Retention,Unspec
 ;;^UTILITY(U,$J,358.3,50536,1,4,0)
 ;;=4^R33.9
 ;;^UTILITY(U,$J,358.3,50536,2)
 ;;=^5019332
